BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22677373)

  • 1. Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors.
    Alsadius D; Hedelin M; Lundstedt D; Pettersson N; Wilderäng U; Steineck G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e181-5. PubMed ID: 22677373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum.
    al-Abany M; Helgason AR; Cronqvist AK; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1035-44. PubMed ID: 15752882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defecation into clothing without forewarning and mean radiation dose to bowel and anal-sphincter among gynecological cancer survivors.
    Lind H; Alevronta E; Steineck G; Waldenström AC; Nyberg T; Olsson C; Wilderäng U; Dunberger G; Al-Abany M; Åvall-Lundqvist E
    Acta Oncol; 2016 Nov; 55(11):1285-1293. PubMed ID: 27173757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy.
    Smeenk RJ; Hoffmann AL; Hopman WP; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):636-44. PubMed ID: 22137024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates.
    Smeenk RJ; Hopman WP; Hoffmann AL; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):145-52. PubMed ID: 20950951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients.
    Mavroidis P; al-Abany M; Helgason AR; Agren Cronqvist AK; Wersäll P; Lind H; Qvanta E; Theodorou K; Kappas C; Lind BK; Steineck G; Brahme A
    Strahlenther Onkol; 2005 May; 181(5):293-306. PubMed ID: 15900425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy.
    Alevronta E; Lind H; Al-Abany M; Waldenström AC; Olsson C; Dunberger G; Mavroidis P; Nyberg T; Johansson KA; Åvall-Lundqvist E; Steineck G; Lind BK
    Acta Oncol; 2013 May; 52(4):719-26. PubMed ID: 23113592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer.
    Thor M; Olsson CE; Oh JH; Petersen SE; Alsadius D; Bentzen L; Pettersson N; Muren LP; Waldenström AC; Høyer M; Steineck G; Deasy JO
    Acta Oncol; 2015; 54(9):1326-34. PubMed ID: 26340136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose to the anal sphincter region and risk of fecal leakage.
    al-Abany M; Helgason AR; Cronqvist AK; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
    Acta Oncol; 2004; 43(1):117-8. PubMed ID: 15068331
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Fokdal L; Honoré H; Høyer M; von der Maase H
    Radiother Oncol; 2005 Feb; 74(2):203-10. PubMed ID: 15734208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pudendal nerve injury impairs anorectal function and health related quality of life measures ≥2 years after 3D conformal radiotherapy for prostate cancer.
    Yeoh EE; Botten R; Di Matteo A; Tippett M; Hutton J; Fraser R; Dinning PG; Wattchow D
    Acta Oncol; 2018 Apr; 57(4):456-464. PubMed ID: 29139310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate.
    Yeoh EK; Holloway RH; Fraser RJ; Botten RJ; Di Matteo AC; Butters J
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e593-9. PubMed ID: 22836050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial.
    Brand DH; Brüningk SC; Wilkins A; Fernandez K; Naismith O; Gao A; Syndikus I; Dearnaley DP; Tree AC; van As N; Hall E; Gulliford S;
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):596-608. PubMed ID: 33412260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT.
    Onjukka E; Fiorino C; Cicchetti A; Palorini F; Improta I; Gagliardi G; Cozzarini C; Degli Esposti C; Gabriele P; Valdagni R; Rancati T
    Acta Oncol; 2019 Dec; 58(12):1757-1764. PubMed ID: 31298076
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate.
    Vordermark D; Schwab M; Ness-Dourdoumas R; Sailer M; Flentje M; Koelbl O
    Radiother Oncol; 2003 Nov; 69(2):209-14. PubMed ID: 14643960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy.
    Heemsbergen WD; Hoogeman MS; Hart GA; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1011-8. PubMed ID: 15752880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancer.
    Kragelj B; Zlatic J; Zaletel-Kragelj L
    Brachytherapy; 2017; 16(1):193-200. PubMed ID: 27908678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST; Lebesque JV; Heemsbergen WD; van Putten WL; Slot A; Dielwart MF; Koper PC
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1151-61. PubMed ID: 16414208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.